HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that the Company has secured new commitment for $13 million in private equity financing. The funds will be used for general corporate purposes. The private placement of common stock is with institutional investors who have participated in previous successful financings for the company, and is priced at a 3% discount to the market price. There are no warrants with the placement and no restrictions on other corporate financing.
